We showed a lower percentage of CD3+, CD4+ and CD25+ T cells in tumours with COX-2 positive immunostaining in tumour cells suggesting that the expression of high levels of COX-2 in tumour cells can play a major role in inhibiting host immune functions. This evidence concerns the gene CD4 and neoplasm.